Mereo BioPharma Group PLC (MREO)
3.20
-0.07
(-2.14%)
USD |
NASDAQ |
May 17, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -1.155M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.155M
Minimum
Jun 2023
-1.155M
Maximum
Jun 2023
-1.155M
Average
-1.155M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | -0.0533M |
TC BioPharm (Holdings) PLC | -- |
Adaptimmune Therapeutics PLC | 29.24M |
Autolus Therapeutics PLC | 0.023M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -7.991M |
Cash from Investing (Quarterly) | -0.70M |
Free Cash Flow Per Share (Quarterly) | -0.0621 |